Abstract:Angiotensin-converting enzyme (ACE) inhibitors are recommended as first-line antihypertensive therapy in many patients.Angiotensin-converting enzyme inhibition leads to the accumulation of bradykinin, a potent vasodilator and likely mediator of ACE inhibitor-induced angioedema. It is estimated that 0.7% of patients prescribed ACE inhibitors develop angioedema within 5 years of starting treatment [1]. Angioedema in the peri-operative period can lead to considerable diagnostic uncertainty as it can be the result… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.